These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 28975278

  • 1. Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis.
    Long JD, Mills JA, Leavitt BR, Durr A, Roos RA, Stout JC, Reilmann R, Landwehrmeyer B, Gregory S, Scahill RI, Langbehn DR, Tabrizi SJ, Track-HD and Track-On Investigators.
    JAMA Neurol; 2017 Nov 01; 74(11):1352-1360. PubMed ID: 28975278
    [Abstract] [Full Text] [Related]

  • 2. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR, TRACK-HD investigators.
    Lancet Neurol; 2012 Jan 01; 11(1):42-53. PubMed ID: 22137354
    [Abstract] [Full Text] [Related]

  • 3. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.
    Huntington Study Group PHAROS Investigators, Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, Siemers E, Tanner C, Mallonee W, Suter G, Dubinsky R, Gray C, Nance M, Bundlie S, Radtke D, Kostyk S, Baic C, Caress J, Walker F, Hunt V, O'Neill C, Chouinard S, Factor S, Greenamyre T, Wood-Siverio C, Corey-Bloom J, Song D, Peavy G, Moskowitz C, Wesson M, Samii A, Bird T, Lipe H, Blindauer K, Marshall F, Zimmerman C, Goldstein J, Rosas D, Novak P, Caviness J, Adler C, Duffy A, Wheelock V, Tempkin T, Richman D, Seeberger L, Albin R, Chou KL, Racette B, Perlmutter JS, Perlman S, Bordelon Y, Martin W, Wieler M, Leavitt B, Raymond L, Decolongon J, Clarke L, Jankovic J, Hunter C, Hauser RA, Sanchez-Ramos J, Furtado S, Suchowersky O, Klimek ML, Guttman M, Sethna R, Feigin A, Cox M, Shannon B, Percy A, Dure L, Harrison M, Johnson W, Higgins D, Molho E, Nickerson C, Evans S, Hobson D, Singer C, Galvez-Jimenez N, Shannon K, Comella C, Ross C, Saint-Hilaire MH, Testa C, Rosenblatt A, Hogarth P, Weiner W, Como P, Kumar R, Cotto C, Stout J, Brocht A, Watts A, Eberly S, Weaver C, Foroud T, Gusella J, MacDonald M, Myers R, Fahn S, Shults C.
    JAMA Neurol; 2016 Jan 01; 73(1):102-10. PubMed ID: 26569098
    [Abstract] [Full Text] [Related]

  • 4. Validation of a prognostic index for Huntington's disease.
    Long JD, Langbehn DR, Tabrizi SJ, Landwehrmeyer BG, Paulsen JS, Warner J, Sampaio C.
    Mov Disord; 2017 Feb 01; 32(2):256-263. PubMed ID: 27892614
    [Abstract] [Full Text] [Related]

  • 5. Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.
    Paulsen JS, Long JD, Ross CA, Harrington DL, Erwin CJ, Williams JK, Westervelt HJ, Johnson HJ, Aylward EH, Zhang Y, Bockholt HJ, Barker RA, PREDICT-HD Investigators and Coordinators of the Huntington Study Group.
    Lancet Neurol; 2014 Dec 01; 13(12):1193-201. PubMed ID: 25453459
    [Abstract] [Full Text] [Related]

  • 6. Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.
    Moss DJH, Pardiñas AF, Langbehn D, Lo K, Leavitt BR, Roos R, Durr A, Mead S, TRACK-HD investigators, REGISTRY investigators, Holmans P, Jones L, Tabrizi SJ.
    Lancet Neurol; 2017 Sep 01; 16(9):701-711. PubMed ID: 28642124
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
    Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, Stout JC, TRACK-HD Investigators.
    Lancet Neurol; 2011 Jan 01; 10(1):31-42. PubMed ID: 21130037
    [Abstract] [Full Text] [Related]

  • 10. Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HD.
    Long JD, Paulsen JS, PREDICT-HD Investigators and Coordinators of the Huntington Study Group.
    Mov Disord; 2015 Oct 01; 30(12):1664-72. PubMed ID: 26340420
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cognitive and Motor Norms for Huntington's Disease.
    Mills JA, Long JD, Mohan A, Ware JJ, Sampaio C.
    Arch Clin Neuropsychol; 2020 Aug 28; 35(6):671-682. PubMed ID: 32407458
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Joint modeling of multivariate longitudinal data and survival data in several observational studies of Huntington's disease.
    Long JD, Mills JA.
    BMC Med Res Methodol; 2018 Nov 16; 18(1):138. PubMed ID: 30445915
    [Abstract] [Full Text] [Related]

  • 19. Huntington's Disease Progression: A Population Modeling Approach to Characterization Using Clinical Rating Scales.
    Sun W, Zhou D, Warner JH, Langbehn DR, Hochhaus G, Wang Y.
    J Clin Pharmacol; 2020 Aug 16; 60(8):1051-1060. PubMed ID: 32416008
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.